Narrow-Bandgap Iridium(III)-C 3 N 5 Nanocomplex as an Oxygen Self-Sufficient Piezo-Sonosensitizer for Hypoxic Tumor Sonodynamic Immunotherapy
Journal of the American Chemical Society · 07.05.2025 · 147 (18) · 15329-15343
DOI: 10.1021/jacs.5c00843 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 28.04.2025. Verfasst von Xianbo Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, State Key Laboratory of Anti-Infective Drug Discovery and Development, Guangdong Basic Re…. Hauptthemen laut MEDLINE: Iridium, Immunotherapy, Ultrasonic Therapy, Nitriles. Die Arbeit wurde bisher 77-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Science and Technology Program of Hunan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Low immunogenicity and insufficient infiltration of immune cells are the main factors affecting the therapeutic efficacy of melanoma immunotherapy. Ultrasound-triggered sonodynamic therapy (SDT) based on piezoelectric materials has attracted substantial attention due to its high efficiency of piezoelectric catalytic generation of reactive oxygen species (ROS) to induce immunogenic cell death (ICD). However, the hypoxic environment in solid tumors hinders the infiltration of immune cells and limits the SDT effect. Herein, we construct a novel Ir-C3N5 nanocomplex that uses nitrogen-rich carbon nitride (C3N5) nanosheets as nanoligands and Ir(tpy)Cl3 as a precursor. The newly formed Ir-C3N5 nanocomplex exhibits a narrowed band gap and an enlarged dipole moment, resulting in a better electron-hole pair separation and band bending, contributing to the ROS burst upon ultrasonic activation. In addition, Ir(III) enables the C3N5 nanosheets to catalyze the degradation of H2O2 to O2, alleviating tumor hypoxia and reinforcing SDT efficacy. Mechanistically, due to the generation of ROS by piezoelectric catalysis, Ir-C3N5 can target lysosomes to trigger autophagy inhibition caused by lysosome rupture and to evoke pyroptosis. More importantly, the cleaved caspase-1/GSDMD-N pyroptosis pathway activated by Ir-C3N5 was associated with ICD, effectively initiating the innate and adaptive immunity of the body for suppressing tumor metastasis and relapse.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, State Key Laboratory of Anti-Infective Drug Discovery and Development, Guangdong Basic Research Center of Excellence for Functional Molecular Engineering, Scho…
- Huangpu Hydrogen Innovation Center/Guangzhou Key Laboratory for Clean Energy and Materials, School of Chemistry and Chemical Engineering, Guangzhou University, Guangzhou 510006, P.R. China.
- MOE Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan 400201, P.R. China.
ORCID-Profile: Xiting Zhang, Hui Chao
Förderung
- Science and Technology Program of Hunan Province
- National Natural Science Foundation of China
Zitieren
APA
Wu, X., Liang, J., Shu, J., Li, Z., Yin, T., Zhang, X., & Chao, H. (2025). Narrow-Bandgap Iridium(III)-C 3 N 5 Nanocomplex as an Oxygen Self-Sufficient Piezo-Sonosensitizer for Hypoxic Tumor Sonodynamic Immunotherapy. Journal of the American Chemical Society, 147(18), 15329-15343. https://doi.org/10.1021/jacs.5c00843
Vancouver
Wu X, Liang J, Shu J, Li Z, Yin T, Zhang X, et al. Narrow-Bandgap Iridium(III)-C 3 N 5 Nanocomplex as an Oxygen Self-Sufficient Piezo-Sonosensitizer for Hypoxic Tumor Sonodynamic Immunotherapy. Journal of the American Chemical Society. 2025;147(18):15329-15343. doi:10.1021/jacs.5c00843
BibTeX
@article{Wu2025,
author = {Wu, Xianbo and Liang, Jinzhe and Shu, Jun and Li, Zeqi and Yin, Tiantian and Zhang, Xiting and Chao, Hui},
title = {Narrow-Bandgap Iridium(III)-C 3 N 5 Nanocomplex as an Oxygen Self-Sufficient Piezo-Sonosensitizer for Hypoxic Tumor Sonodynamic Immunotherapy},
journal = {Journal of the American Chemical Society},
year = {2025},
volume = {147},
number = {18},
pages = {15329--15343},
doi = {10.1021/jacs.5c00843}
}
EUVIMED